v3.25.2
BASIS OF FINANCIAL STATEMENT PRESENTATION (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Disaggregation of Revenue [Line Items]        
Percent of Revenue Contributed 100.00% 100.00% 100.00% 100.00%
Ownership percentage below which investments are generally accounted for on the cost method (in thousandths)     20.00%  
Biopharma Laboratory Services        
Disaggregation of Revenue [Line Items]        
Percent of Revenue Contributed 22.00% 22.00% 22.00% 22.00%
Diagnostics        
Disaggregation of Revenue [Line Items]        
Percent of Revenue Contributed 78.00% 78.00% 78.00% 78.00%